Scientist, Nonclinical Safety at Gilead Sciences

Foster City, California, United States

Gilead Sciences Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, PharmaceuticalIndustries

Requirements

  • PhD in toxicology, pharmacology, or related scientific discipline with 2+ years experience in small molecule and/or biopharmaceutical drug development desirable, or BS or MS with extensive industry experience in nonclinical safety assessment
  • Board certification or eligibility is desirable
  • Good scientific expertise in subject area/discipline; familiar with other disciplines (e.g., pathology, pharmacology, drug metabolism)
  • Familiarity with ICH and GLP
  • Manage multiple projects simultaneously with minimal supervision
  • Excellent self-management and organizational skills, and ability to manage high volume workload
  • Clear and concise oral and written communication skills
  • Strong motivation, independence, and ability to work in a multidisciplinary, matrix environment with minimal supervision
  • Team player who thrives in a high-speed environment where autonomy, accountability, and innovation are critical

Responsibilities

  • Serve as the toxicology representative on multifunctional project teams
  • Ownership of the nonclinical safety program
  • Contribute to regulatory documents to support drug development candidates across a variety of platforms from early research through registration/post approval
  • Provide critical review and interpretation of protocols, data, and study reports
  • Actively support the integration of early nonclinical safety strategies throughout Research
  • Solve moderately complex problems requiring thorough scientific assessment
  • Effectively communicate project development plans and study results to project teams and Senior level management

Skills

Nonclinical Safety
Pathobiology
Toxicology
Research
Biopharmaceutical Development

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters
1987Year Founded
$15,873.6MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Paid family time off and paid parental time off
Generous 401(k) contribution matching
Comprehensive medical plans that cover both physical and mental healthcare
Global Wellbeing Reimbursement
Time Off
Global Volunteer Day
Giving Together Program
Employee Support Programs
Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.
Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.
Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.
Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.
Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.
Investment in digital health technologies enhances Gilead's R&D and patient engagement.
Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI